Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. SC 13G Stake Amended Statement of Ownership
  2. 8-K Event Other events
  3. SC 13D Stake Beneficial Ownership Report
  4. SC 13D Stake Beneficial Ownership Report
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Bylaws or fiscal year change
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 424B4 Offering Prospectus
  18. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  19. EFFECT Other Notice of Effectiveness
  20. 3 Insider Initial Statement of Ownership

Page 19 of 21 · 403 filings